Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-19 Sale | 2025-03-20 7:38 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 1,295 | $71.52 | $92,618 | 16,955 (Direct) | View |
| 2025-03-06 Sale | 2025-03-07 4:06 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 7,034 | $71.28 | $501,355 | 87,655 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 8:21 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 1,344 | $68.38 | $91,903 | 13,105 (Direct) | View |
| 2024-11-12 Sale | 2024-11-14 2:44 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 5,278 | $66.37 | $350,324 | 68,909 (Direct) | View |
| 2024-08-13 Sale | 2024-08-15 3:57 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 714 | $90 | $64,260 | 14,449 (Direct) | View |
| 2024-05-30 Sale | 2024-05-31 6:28 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 5,000 | $75.19 | $375,950 | 72,159 (Direct) | View |
| 2024-05-28 Sale | 2024-05-30 6:18 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 40,850 | $74.51 | $3,043,802 | 56,157 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-14 Tax Withholding | 2025-03-18 7:53 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 823 | $69.44 | 27,482 (Direct) | View |
| 2025-03-17 Option Award | 2025-03-18 7:53 pm | 2026-03-17 2035-03-16 | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 15,200 | $0 | 27,482 (Direct) | View |
| 2025-03-14 Tax Withholding | 2025-03-18 7:51 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 16,249 | $69.44 | 112,935 (Direct) | View |
| 2025-03-17 Option Award | 2025-03-18 7:51 pm | 2026-03-17 2035-03-16 | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 42,960 | $0 | 112,935 (Direct) | View |
| 2025-03-17 Option Award | 2025-03-18 6:25 pm | 2026-03-17 2035-03-16 | BIOMARIN PHARMACEUTICAL INC | BMRN | Hubbard Cristin EVP, Chief Commercial Officer | 44,190 | $0 | 63,580 (Direct) | View |
| 2025-03-17 Option Award | 2025-03-18 6:23 pm | 2026-03-17 2035-03-16 | BIOMARIN PHARMACEUTICAL INC | BMRN | Friberg Gregory R EVP, Chief R&D Officer | 58,920 | $0 | 87,980 (Direct) | View |
| 2025-03-14 Tax Withholding | 2025-03-18 6:22 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 20,127 | $69.44 | 111,718 (Direct) | View |
| 2025-03-17 Option Award | 2025-03-18 6:22 pm | 2026-03-17 2035-03-16 | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 44,190 | $0 | 111,718 (Direct) | View |
| 2025-03-14 Tax Withholding | 2025-03-18 6:19 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 18,497 | $69.44 | 138,371 (Direct) | View |
| 2025-03-17 Option Award | 2025-03-18 6:19 pm | 2026-03-17 2035-03-16 | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 55,230 | $0 | 138,371 (Direct) | View |
| 2025-03-14 Tax Withholding | 2025-03-18 6:17 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Hardy Alexander Chief Executive Officer | 2,933 | $69.44 | 237,333 (Direct) | View |
| 2025-03-17 Option Award | 2025-03-18 6:17 pm | 2026-03-17 2035-03-16 | BIOMARIN PHARMACEUTICAL INC | BMRN | Hardy Alexander Chief Executive Officer | 106,110 | $0 | 237,333 (Direct) | View |
Ownership(A) | 2025-03-07 4:03 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Walbert Timothy P Director | 0 | $0 | 416 (Indirect) | View |
| 2025-02-28 Tax Withholding | 2025-03-04 4:11 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 4,287 | $71.16 | 94,689 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-27 7:19 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 30,067 | $0 | 101,638 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-27 7:17 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 30,067 | $0 | 98,976 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-27 7:15 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 30,067 | $0 | 86,224 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-26 4:18 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Walbert Timothy P Director | 3,130 | $0 | 3,130 (Direct) | View |
| 2024-10-31 Option Award | 2024-12-03 6:15 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Hardy Alexander Chief Executive Officer | 300 | $56.01 | 134,156 (Direct) | View |
| 2024-11-29 Tax Withholding | 2024-12-03 6:15 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Hardy Alexander Chief Executive Officer | 14,295 | $66.03 | 134,156 (Direct) | View |
| 2024-10-31 Option Award | 2024-11-14 2:44 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 55 | $56.01 | 68,909 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-01 4:51 pm | 2025-09-30 2034-09-29 | BIOMARIN PHARMACEUTICAL INC | BMRN | Friberg Gregory R EVP, Chief R&D Officer | 78,910 | $0 | 78,910 (Direct) | View |
| 2024-09-13 Tax Withholding | 2024-09-17 5:54 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 12,098 | $84.9 | 185,074 (Direct) | View |
| 2024-04-30 Option Award | 2024-09-17 5:54 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 300 | $68.65 | 185,074 (Direct) | View |
| 2024-06-28 Tax Withholding | 2024-07-01 4:19 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 588 | $82.33 | 71,571 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 7:29 pm | 2014-09-04 2024-06-03 | BIOMARIN PHARMACEUTICAL INC | BMRN | HERON ELAINE J Director | 5,047 | $0 | 97,720 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 7:29 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | HERON ELAINE J Director | 5,047 | $63.1 | 97,720 (Direct) | View |
| 2024-06-03 Tax Withholding | 2024-06-04 7:29 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | HERON ELAINE J Director | 4,168 | $76.41 | 97,720 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 7:28 pm | 2014-09-04 2024-06-03 | BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director | 6,600 | $0 | 120,776 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 7:28 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director | 6,600 | $63.1 | 120,776 (Direct) | View |
| 2024-06-03 Tax Withholding | 2024-06-04 7:28 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director | 5,451 | $76.41 | 120,776 (Direct) | View |
| 2024-05-30 Exercise | 2024-05-31 6:28 pm | 2014-12-04 2024-06-03 | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 5,000 | $0 | 72,159 (Direct) | View |
| 2024-04-30 Option Award | 2024-05-31 6:28 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 300 | $68.65 | 72,159 (Direct) | View |
| 2024-05-30 Exercise | 2024-05-31 6:28 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 5,000 | $63.1 | 72,159 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 6:18 pm | 2014-12-04 2024-06-30 | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 40,850 | $0 | 56,157 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 6:18 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 40,850 | $63.1 | 56,157 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:36 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | PYOTT DAVID E I Director | 4,720 | $0 | 49,750 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:34 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director | 7,080 | $0 | 119,627 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:33 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | HOMBACH ROBERT J. Director | 4,720 | $0 | 35,220 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:30 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Ho Maykin Director | 4,720 | $0 | 21,360 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:26 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | HERON ELAINE J Director | 4,720 | $0 | 96,841 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:23 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Enyedy Mark J Director | 4,720 | $0 | 6,900 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:20 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Dere Willard H Director | 4,720 | $0 | 32,300 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:14 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Countouriotis Athena Director | 4,720 | $0 | 6,900 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:08 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Bodem Barbara W. Director | 4,720 | $0 | 6,900 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:06 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | ANDERSON ELIZABETH M Director | 4,720 | $0 | 27,800 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-22 4:36 pm | 2025-05-20 2034-05-19 | BIOMARIN PHARMACEUTICAL INC | BMRN | Hubbard Cristin EVP, Chief Commercial Officer | 52,910 | $0 | 52,910 (Direct) | View |